25,143.05
+580.81
(+2.36%)
8,381.90
+245.17
(+3.01%)
4,752.15
+128.98
(+2.79%)
3,796.28
+32.13
(+0.854%)
4,598.32
+69.22
(+1.528%)
13,610.23
-96.65
(-0.705%)
65,224.9900
+502.4400
(0.776%)
26/02/2026 13:03
大行報告 | 滙控績後最新評級/目標價,生物股邊隻好?一表盡掌握
.三間大行績後看好滙控(00005),其中華泰看好166.07元
.瑞銀上調生物股,其中藥明康德(02359)目標價由138.4元上調至153.1元
.瑞銀下調科濟藥業(02171)及諾誠健華(09969)目標,分別看27元及21.1元
1069,,新聞,專題透視,reports